| Term 
 
        | 1) Amoxil, Trimox, Generic 
 2) Cell wall synth inhbitor
 
 3) Upper respiratory tract infections, including otitis media and sinusitis, UTIs
 |  | Definition 
 
        | AMOXICILLIN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Augmentin 
 2) bacterial cell wall synth inhibitor + beta lactamase inhibitor
 
 3) Upper resp. tract infxns  (otitis med & sinusitis)
 -UTI's
 -diabetic foot ulcer
 -community acquired pneumonia
 |  | Definition 
 
        | AMOXICILLIN + CLAVULANATE 
 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Zithromax, Zpak 
 2) Macrolide abx, binds to 50s subunit of bac to suppress protein synth
 
 3) Upper & lower resp. tract infxns:
 -sinusitis
 -comm. aquired pneumonia
 -acute exacerbation of chronic bronchitis
 -also covers chlamydia, legionella, and mycoplasma
 |  | Definition 
 
        | AZITRHOMYACIN 
 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Keflex, generic 
 2) bacterial cell wall synth inhibitor (1st gen cephalosporin)
 
 3) Skin & soft tissue infxns, UTIs
 |  | Definition 
 
        | CEPHALEXIN 
 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Cipro 
 2) DNA gyrase inhibitor
 
 3) UTIs, G- suspected systemic infxn, gonorrhea
 |  | Definition 
 
        | CIPROFLOXACIN 
 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Ery-tab, generic 
 2) Macrolide, binds to bac. 50s subunit to supress protein synth
 
 3) penicillin alternative:
 -Upper & lower resp. tract infections
 -skin & soft tissue infxns
 -covers chlamydia, mycoplasma, legionella
 |  | Definition 
 
        | ERYTHROMYACIN 
 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Levaquin 
 2)  Quinolone, DNA gyrase inhibitor
 
 3) UTIs, Com aquired pneumonia, gonorrhea
 |  | Definition 
 
        | LEVOFLOXACIN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Bactrim, Septra, Generic 
 2) Abx; sequential antimetabolite
 
 3)  UTIs
 -upper resp infx (otitis, sinusitis)
 -skin & soft tissue infxn (comm aquired MRSA)
 |  | Definition 
 
        | TRIMETHOPRIM/SULFAMETHAZOLE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) none 
 2) calcium channel antagonist
 
 3) HTN
 |  | Definition 
 
        | AMLODIPINE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) generic 
 2) Acetylates platelet cyclooxygenase (cox), inhibits prostaglandin synthase
 
 3) antiplatelet (post MI, stroke)
 -antiinflammatory
 -antipyretic
 -analgesic
 |  | Definition 
 
        | ASPIRIN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) lipitor 
 2) HMGCoA reductase inhibitor (blocks endogenous cholesterol synth)
 
 3) Hypercholsterolemia
 -mixed hyperlipidemia (both cholesterol and triglyceride elevation)
 |  | Definition 
 
        | ATORVASTATIN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Atacand 
 2) Angiotensin receptor blocker
 
 3) HTN, CHF, left ventricular dysfunction
 |  | Definition 
 
        | CANDESARTAN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Plavix 
 2) selective and irreversible inhibitor of  platelet activation by binding to ATP dependent receptor on platelets
 
 3) antiplatlet
 |  | Definition 
 
        | CLOPIDOGREL 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Cardizem, Tiazac 
 2) Ca++ channel blocker
 
 3) HTN
 -Angina
 -Slow heart rate in supraventricular tachycardias
 |  | Definition 
 
        | DILTIAZEM 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Monopril 
 2) ACE inhibitor
 
 3) HTN, CHF
 |  | Definition 
 
        | FOSINOPRIL 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Lasix 
 2) blocks Na+ reabsorption in ascending LoH
 
 3) (loop) diuretic
 |  | Definition 
 
        | FUROSEMIDE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Lopid, Generic 
 2) Increases LPL activity and decreases VLDL synth in the liver
 
 3) hypertriglyceridemia
 |  | Definition 
 
        | GEMFIBROZIL 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) generic 
 2) blocks Na+ reabsorption in the proximal part of the DCT
 
 3) (thiazide) diuretic, HTN
 |  | Definition 
 
        | HYDROCHLOROTHIAZIDE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Prinivil, Zestril 
 2) ACE inhibitor
 
 3) HTN, CHF
 |  | Definition 
 
        | LISINOPRIL 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Cozaar 
 2) Angiotensin II receptor antagonist
 
 3) HTN, Neuropathy in DM type 2
 |  | Definition 
 
        | LOSARTAN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Lopressor, Toprol XL, Generic 
 2) selective beta 1 receptor antagonist
 
 3) HTN
 -Angina
 -Heart failure
 -post MI
 |  | Definition 
 
        | METOPROLOL 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Procardia, Adalat, generic 
 2) Ca++ channel antagonist
 
 3) HTN
 |  | Definition 
 
        | NIFEDIPINE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Inderal, generic 
 2) non-selective B1 & 2 receptor antagonist
 
 3) HTN, angina, slow HR, Migraine
 |  | Definition 
 
        | PROPANOLOL 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Zocor 
 2) HMGCoA reductase inhibitor
 
 3) hypercholesterolemia
 -mixed hyperlipidemia (both triglycerides and cholesterol elevated)
 |  | Definition 
 
        | SIMVASTATIN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Hytrin 
 2) alpha 1 receptor antagonist
 
 3) HTN, prostatic hypertrophy
 |  | Definition 
 
        | TERAZOSIN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Calan, Isoptin, Generic 
 2) Ca+ channel antagonist
 
 3) HTN, angina, SLOW HR, supraventricular tachy-arrythmias
 |  | Definition 
 
        | VERAPAMIL 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Coumadin, generic 
 2) Vitamin K antagonist
 
 3) anticoagulation
 |  | Definition 
 
        | WARFARIN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Diabeta, Micronase, Generic 
 2) Sulfonylurea antidiabetic agent that increases insulin secretion from the pancreas
 
 3) DM type 2
 |  | Definition 
 
        | GLYBURIDE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Humalog, Novolog, Apidra 
 2) Binds to endogenous insulin receptor
 
 3) DM type 1 or 2
 |  | Definition 
 
        | INSULIN RAPID/SHORT ACTING, LISPRO, GLUISINE, REGULAR 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Humulin N, Lantus, Levemir 
 2) binds to endogenous insulin receptor
 
 3) DM type 1 or 2
 |  | Definition 
 
        | INSULIN INTERMED/LONG ACTING, NPH, GLARGINE, DETEMIR 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Glucophage 
 2) biguanide antidiabetic; decrease hepatic glc pdxn and increases insulin sensitivity
 
 3) DM type 2
 |  | Definition 
 
        | METFORMIN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Avandia 
 2)  Insulin sensitizer, improves insulin action in the presence of insulin
 
 3) DM type 2
 |  | Definition 
 
        | ROSIGLITAZONE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Januvia 
 2) DPP-4 inhibitor
 
 3) DM type 2
 |  | Definition 
 
        | SITAGLIPTIN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Nexium 
 2) H-K ATPase enzyme inhibitor, blocks gastric acid secretion
 
 3) GERD
 |  | Definition 
 
        | ESOMEPRAZOLE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Pepcid 
 2) histamine 2 receptor blocker, reduce gastric acidity
 
 3) duodenal ulcer, gastric ulcer, GERD
 |  | Definition 
 
        | FAMOTIDINE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Prilosec 
 2) H-K ATPase inhibitor, blocks gastric secretion
 
 3) duodenal ulcer, gastric ulcer, GERD
 |  | Definition 
 
        | OMEPRAZOLE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Zantac 
 2) histamine 2 receptor blocker, reduces gastric acidity
 
 3) duodenal ulcer, gastric ulcer, GERD
 |  | Definition 
 
        | RANITIDINE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) proventil, ventolin, generic 
 2) short acting selective Beta 2 agonist
 
 3) bronchodilator
 |  | Definition 
 
        | ALBUTEROL 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Zyrtec 
 2) nonsedating antihistamine
 
 3) allergic sinusitis/ rhinitis
 |  | Definition 
 
        | CETIRIZINE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Flovent, flonase 
 2) inhibits phospholipase A2 and other multiple anti-inflammatory actions
 
 3) inhaled anti-inflammatory agent for treatment of persistent asthma, Nasal for allergic rhinitis
 |  | Definition 
 
        | FLUTICASONE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) atrovent 
 2) cholinergic receptor antagonist
 
 3) bronchodilator for COPD
 |  | Definition 
 
        | IPRRATROPIUM 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Singulair 
 2) leukotriene receptor antagonist
 
 3) mild persistent asthma
 |  | Definition 
 
        | MONTELUKAST 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) deltazone, generic 
 2) inhibits phospholipase A2 and other multiple anti-inflammatory actions
 
 3) oral antiinflammatory agent for treatment of multiple inflammatory conditions
 |  | Definition 
 
        | PREDNISONE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) serevent 
 2) long acting, selective beta 2 receptor agonist
 
 3) bronchodilator
 |  | Definition 
 
        | SALMETEROL 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) welbutrin, Zyban, generic 
 2) norepinephrine and dopamine reuptake inhibitor
 
 3) antidepressant, smoking cessation
 |  | Definition 
 
        | BUPROPION 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) pristiq 
 2) serotonin-norepi reuptake inhibitor  (SSRI)
 
 3) depression
 -social anxiety disorder
 -generalized anxiety disorder
 -panic disorder
 |  | Definition 
 
        | DESVENLAFAXINE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) valium, generic 
 2) benzodiazepine receptor agonist
 
 3) muscle relaxant
 -anxiolytic
 -anticonvulsant
 -alcohol withdrawl
 |  | Definition 
 
        | DIAZEPAM 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) cymbalta 
 2) SSRI
 
 3) depression, pain
 |  | Definition 
 
        | DULOXETHINE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Lexapro 
 2) SSRI
 
 3) depression, generalized anxiety disorder
 |  | Definition 
 
        | ESCITALOPRAM 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Neurontin 
 2) unkown
 
 3) anticonvulsant, neuropathy
 |  | Definition 
 
        | GABAPENTIN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Ativan, generic 
 2) benzodiazepine receptor agonist
 
 3) anxiolytic, anticonvulsant, antiemetic (combined with other agents), alcohol withdrawl
 |  | Definition 
 
        | LORAZEPAM 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Paxil 
 2) SSRI
 
 3) depression, social anxiety disorder, generalized anxiety disorder, panic disorder
 |  | Definition 
 
        | PAROXETINE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) dilantin, generic 
 2) Na+ channel blocker
 
 3) anticonvulsant
 |  | Definition 
 
        | PHENYTOIN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Zoloft 
 2) SSRI
 
 3) depression, OCD, panic attacks
 |  | Definition 
 
        | SERTRALINE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Topamax 
 2) Na channel blocker, glutamate receptor blocker
 
 3) anticonvulsant, neuropathy, migraine headaches
 |  | Definition 
 
        | TOPIRAMATE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Celebrex 
 2) selective cyclooxygenase-2 inhibitor, inhibits prostaglandin production
 
 3) analgesic, antiinflammatory
 |  | Definition 
 
        | CELECOXIB 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Advil, motrin, Motrin IB, generic 
 2) inhibits cyclooxygenase: inhibits prostaglandin synthesis
 
 3) antiinflammatory, analgesic, antipyretic
 |  | Definition 
 
        | IBUPROFEN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) MS Contin, Oramorph, Other 
 2) opiate agonist
 
 3) analgesic
 |  | Definition 
 
        | MORPHINE 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Aleve, Naprosyn, Anaprox, generic 
 2) inhibits cyclooxygenase: inhibits prostaglandin production
 
 3) antiinflammatory, analgesic, antipyretic
 |  | Definition 
 
        | NAPROXEN 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Lorabid, Percocet, generic 
 2) opiate agonist
 
 3) analgesic
 |  | Definition 
 
        | OXYCODONE (alone or with ACETOMINOPHEN) 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  | 
        
        | Term 
 
        | 1) Oxycontin 
 2) opiate agonist
 
 3) analgesic
 |  | Definition 
 
        | OXYCODONE SUSTAINED RELEASE (alone or with ACETAMINOPHEN) 
 List the
 1) trade name(s)
 2) mechanism of action
 3) predominant therapeutic uses
 |  | 
        |  |